Turkish Cargo reaches pharma transport milestone

By Damian Brett

Turkish Cargo is celebrating the carriage of medical and pharma products over the last 25 years.

The cargo business has carried Turkey’s medicine and medical products to over 50 countries in five continents over that period of time.

Today, Turkish Cargo boasts an 8% market share in the transportation of pharma as air cargo.

The airline highlighted its partnership with Eczacıbaşı-Monrol Nuclear Products, which started in 1995.

The pharma company specialises in the production of nuclear medicine for the treatment of cancer that require specialist handling.

Its products are flown by CEIV Pharma accredited Turkish Cargo to Germany, Colombia, India, Algeria and Taiwan, amongst other countries.

Eczacıbaşı-Monrol Nuclear Products General Manager Aydın Küçük said: As Turkey’s first radiopharmaceutical manufacturer, we are one of the significant producers of nuclear medicine for cancer treatment in the world and we export our products to over 50 countries.

“We can deliver these successes to patients all around the world from Europe, Africa, America and Far East thanks to our strong logistical operation. With this in mind, Turkish Cargo is one of our strongest supporters since 1995 with its speed, operational quality and wide transportation network.”

Share this story

Related Topics

Latest uncategorized news

K+N profits surge with capacity constraints set to persist

By Damian Brett

Kuehne+Nagel (K+N) saw profits and air volumes soar in the third quarter thanks to higher rates in air and ocean…

Read More

Share this story

Geodis promotes Jordan to EVP and COO Americas

By Rachelle Harry

Geodis has promoted Anthony Jordan into the role of executive vice president (EVP) and chief operating officer (COO), Americas. Jordan,…

Read More

Share this story

Vallair places its last B737-400F as it looks to the future

By Damian Brett

Vallair has placed its last-ever B737-400 freighter as it switches its focus to newer models. The aviation company said that…

Read More

Share this story